entertainment -WSS

entertainment

author：entertainment 2025-09-27 09:53:55 - browse：79

A heart monitoring watch, referred as Project Zero 2.0 is displayed in the Omron Healthcare booth during a press event – health tech coverage from STAT — Digital tools to better track blood pressure over time and encourage adherence to treatment plans are increasingly commonplace. David Becker/Getty Images

If you have high blood pressure, it’s increasingly likely that your doctor or your insurer will offer you a blood pressure cuff or an educational app to help you get it under control. While potentially impactful, these tools may not be reaching marginalized people who don’t regularly have access to good health care — and who may benefit the most from the tools.

A new analysis suggests that there ought to be more investment in novel hypertension programs for people experiencing health disparities.The meta-review of 28 studies of digital health interventions for people of color and low-income patients found that as a whole participants saw a statistically significant and clinically meaningful reduction in average systolic blood pressure compared to control groups. In total, the analysis included more than 8,000 participants; most of the studies followed participants for six or 12 months. The results, published Wednesday in JAMA Network Open, are consistent with studies of digital tools in the general population.

Joseph Ebinger, of the Smidt Heart Institute at Cedars-Sinai in Los Angeles, who was not involved in the study, said it provides needed evidence that “there are tools that exist to be able to help meet individuals where they are in the world, and they should be utilized more heavily.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Hospitals need to get ahead of regulations on climate change

WSS

3 hurdles to bringing medical devices to the U.S. market

The story of mRNA: From a loose idea to a tool that may help curb Covid

Congress: Prevent baby formula shortages by passing a new bill

Cloning humans is technically possible. It's curious no one has tried

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Protect nursing home residents from future pandemics

entertainment

entertainment

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Asahi Kasei to buy Calliditas, picking up kidney disease drug

In Memoriam: Notable people who died in 2023

Decentralized clinical trials need collaboration to achieve wider use

Continuity nursing helped my family in our darkest PICU moments

Some medical students still think black patients feel less pain

In Memoriam: Notable people who died in 2023

New guidelines on severe brain injury complicate already difficult decisions

Hepatitis C has a cure — but many Americans still lack access to it

Lawsuit challenges CMS nursing home minimum staffing rule

explore

The Bio Revolution is changing business and society

Unmasking the 'centricity' illusion in clinical trials

STAT's guide to the next generation of CAR

Bird flu makes raw milk dangerous to consume, mouse study finds

Ask STAT: What do you want to know about ChatGPT in medicine?

Gene therapy has helped boys walk. Can scientists keep it that way?

focus

knowledge

explore

explore